2022 Synapse Faculty
faculty icon


Stephen M. Stahl, MD, PhD, DSc (Hon.)

Clinical Professor, Department of Psychiatry and Neuroscience, University of California, Riverside School of Medicine, Riverside, CA

Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA

Honorary Visiting Senior Fellow, University of Cambridge, Cambridge, UK

Editor-in-Chief, CNS Spectrums

Director of Psychopharmacology Services, California Department of State Hospitals, Sacramento, CA

Dr. Stephen M. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, as a member of the Honors Program in Medical Education, and his Ph.D. degree in pharmacology and physiology from the University of Chicago. Dr. Stahl has trained in three specialties: internal medicine at the University of Chicago; neurology at the University of California in San Francisco; and psychiatry at Stanford University. He is board certified in psychiatry.

Dr. Stahl has held faculty positions at Stanford University, the University of California at Los Angeles (UCLA), the Institute of Psychiatry London, the Institute of Neurology London, and, currently, as professor at the University of California at San Diego (UCSD) and as an Honorary Visiting Senior Fellow in the Department of Psychiatry at the University of Cambridge in the UK. He also directs psychopharmacology services and academic programs for the eight-facility, 6500 patient California Department of State Hospital System, where he also heads their assessment and treatment efforts to reduce violence. Dr. Stahl was formerly Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK for several years. Dr. Stahl’s major interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the internet and teaching how to teach.

Dr. Stahl currently serves as editor-in-chief of CNS Spectrums. He is also past associate editor of Acta Psychiatrica Scandinavica, former clinical field editor for the International Journal of Neuropsychopharmacology and is currently on numerous editorial boards of other leading journals including the ACNP’s journal Neuropsychopharmacology. He has conducted numerous research projects during his career awarded by the National Institute of Mental Health (NIMH), by the Department of Veteran Affairs (VA) and by the pharmaceutical industry. Author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, Dr. Stahl is an internationally renowned clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has written 35 books and edited 12 others, including the best-selling and award-winning textbook, Stahl’s Essential Psychopharmacology, now in its fourth edition, the best-selling and award winning clinical manual, Essential Psychopharmacology Prescriber's Guide, now in its sixth edition.

Lectures, courses and preceptorships based upon his textbooks have taken him to dozens of countries on 6 continents to speak to tens of thousands of physicians, mental health professionals and students at all levels. His lectures and scientific presentations have been distributed as more than a million CD-ROMs, internet educational programs, videotapes, audiotapes and programmed home study texts for continuing medical education to hundreds of thousands of professionals in many different languages. His courses and award-winning multimedia teaching materials are used by psychopharmacology teachers and students throughout the world.

Dr. Stahl serves as a fellow of the ACNP (American College of Neuro-psychopharmacology), of the British Association of Psychopharmacology (BAP) and of the CINP, where he was formerly vice president and is a Distinguished Life Fellow of the American Psychiatric Association (APA). He also has served on numerous medical and scientific advisory boards for the pharmaceutical industry, for the biotechnology and medical information industry, and for various nonprofit and public service organizations, including appointment by the State of California and past Chair of the Medi-Cal Oversight Board for Medicines (Drug Utilization Review Board).

His educational research programs are monitoring changes in diagnosing and prescribing behaviors as outcomes from various educational interventions for programs organized by the Neuroscience Education Institute, which he chairs. He also has an active clinical practice specializing in psychopharmacologic treatment of resistant cases.

He has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education for his contributions to postgraduate education in psychiatry and neurology. His books have won the British Medical Association’s Book of the Year Award and Arbor Scientia has been awarded the business of the year award from the local chamber of commerce. Dr. Stahl is also the winner of the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD department of psychiatry residency teaching award, and has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America.” He was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecture for 2013. Recently, his alma mater Northwestern University honored him by naming their annual award for the best medical student going into psychiatry the Stephen Stahl award. Dr. Stahl was named the 2016 David A Mrazek Memorial Award Winner by the American Psychiatric Association and delivered the Mrazek Lecture at the annual meeting of the APA.

read more +

Laxman B. Bahroo, DO

Associate Professor and Residency Program Director, Department of Neurology, MedStar Georgetown University Hospital Pasquerilla Healthcare Center, Washington, DC

Dr. Laxman B. Bahroo is an assistant professor and co-director of the Neurology Residency Program at MedStar Georgetown University Hospital. He attended medical school in New Jersey, and he completed an internship at Saint Luke's Hospital in Bethlehem, Pa. Dr. Bahroo completed his neurology residency as served as the Academic Chief Resident in his final year at MedStar Georgetown University Hospital. He also completed a two-year fellowship in movement disorders at MedStar Georgetown University Hospital. As a board-certified neurologist and member of the Movement Disorders program, his primary areas of focus in movement disorders include the medical and surgical management of Parkinson's disease and essential tremor. He also specializes in therapeutic botulinum toxin injections for dystonia spasticity and excessive drooling.

read more +

Nicole Ballinger, DO, MPH, FAPA

Medical Staff President/Director, Child and Adolescent Psychiatry Partial Hospital Program, Aurora Psychiatric Hospital, Wauwatosa, WI

Clinical Associate Professor, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin and Affiliated Hospitals, Milwaukee, WI

Site Director, Child and Adolescent Psychiatry Fellow and Resident training, Aurora Psychiatric Hospital, Wauwatosa, and Medical College of Wisconsin, Milwaukee, WI

Dr. Nicole Ballinger received her undergraduate degree from the United States Air Force Academy, her Master’s in Public Health from the University of Illinois Chicago, and her Medical Degree from the University of Health Sciences in Kansas City, Missouri. Dr. Ballinger served on Active Duty in the United Stated Air Force for over 20 years, retiring as a Lieutenant Colonel.  During her early career, she was a Personnel Officer at Andrews AFB, MD and then the Operations Officer for the Chicago Military Entrance Processing Station. She earned a Health Professions Scholarship that sponsored her medical school education and then transitioned into the Medical Corps. She completed residencies in both Family Medicine and Psychiatry with training at Walter Reed Army Hospital and Bethesda Naval Hospital. She was selected for fellowship training in Child and Adolescent Psychiatry, which she completed at the Medical College of Wisconsin. She served as a Child Psychiatrist at Spangdahlem AB in Germany, followed by a tour of duty as the base Psychiatrist and Mental Health Medical Director for Luke AFB in Phoenix, AZ.  Dr. Ballinger is currently the President of the Medical Staff at the Aurora Psychiatric Hospital (APH) in Wauwatosa, WI and the Director of the Child and Adolescent Partial Hospital Program.  She is also an Associate Clinical Professor of Psychiatry at the Medical College of Wisconsin and site director for resident and fellow education in Child and Adolescent Psychiatry at APH. Dr. Ballinger also serves as faculty for the Neuroscience Education Institute and is a member of the Editorial Board for CNS Spectrums.

read more +

Leslie Citrome, MD, MPH

Clinical Professor, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY

Dr. Leslie Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation.

Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm.

Dr. Citrome is the author or co-author of over 400 research reports, reviews, and chapters in the scientific literature, is on the editorial board of 13 different medical journals, reviews for over 90 journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

read more +

Andrew J. Cutler, MD

Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CA

Dr. Andrew J. Cutler attended Haverford College in Philadelphia, Pennsylvania, earning a BS in Biology.  He received his MD from the University of Virginia School of Medicine, where he was also elected to the Alpha Omega Alpha (AOA) honor medical society and received the Merck Award for outstanding medical scholarship. He completed his Medical internship, Internal Medicine residency and Psychiatry residency at the University of Virginia Medical Center, where he served as Chief Resident of Psychiatric Medicine and did research on dopamine receptor pharmacology in the lab of James P. Bennett, MD, PhD.  Dr. Cutler then served as the first Assistant Professor and Director of Psychiatric Medicine at the University of Chicago.  He has been Board Certified in both Internal Medicine and Psychiatry.

Dr. Cutler has been Principal Investigator (PI) on over 400 psychiatric and medical clinical trials.  

Dr. Cutler has authored over 50 peer-reviewed scientific articles and has authored and presented over 100 abstracts/posters at various scientific meetings.  He serves as a peer reviewer for many prestigious scientific and medical journals and serves or has served on several Editorial Boards.  He has chaired or attended over 200 Scientific Advisory Boards, delivered over 3,000 pharmaceutical promotional talks and over 250 invited CME lectures and Grand Rounds presentations.  He has also done over 30 national satellite television medical education broadcasts and over 100 national medical web conferences.

Dr. Cutler is a member of several professional organizations, including the American Psychiatric Association, the Florida Psychiatric Society and the American Medical Association.  He has earned the Certified Physician Investigator (CPI) distinction from the Academy of Physicians in Clinical Research (formerly the Academy of Pharmaceutical Physicians and Investigators). He is a Fellow of the American Psychiatric Association and the Academy of Psychosomatic Medicine. He has received several professional honors and awards including the Merck Award for outstanding medical scholarship, the University of Virginia Pride Award for outstanding patient care, the William Sorum Award from the American Psychiatric Association, the Outstanding Congressional Fellow Award from the 103rd U.S. Congress, a citation from Florida Hospital for outstanding patient care and the Distinguished Clinical Professional Award from the Mental Health Association of Central Florida. He presents research posters and teaches at professional meetings and has published numerous articles in scientific and medical journals. Dr. Cutler frequently gives talks to community groups and national audiences, and often appears as a medical expert in the local and national media. 

read more +

Kari L. Franson, PharmD, PhD, BCPP

Professor, Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles, CA

Dr. Kari L. Franson joined the University of Southern California in 2020 as the Associate Dean for Academic and Student Affairs and Professor of Clinical Pharmacy. Dr. Franson received her Doctor of Pharmacy from the University of California, San Francisco, trained at the University of Illinois, Chicago Hospital and Clinics as a resident in adult internal medicine and a fellow in clinical research/drug development, and received her PhD in Medical Education from Leiden University, the Netherlands.

Dr. Franson is an educator with more than 25 years of experience. Throughout her career, she has focused on two areas: health professions education and psychopharmacology.

She is an international leader in interprofessional practice, education and advocacy and workforce development to address health disparities in both the US and abroad. Dr. Franson has experience in campus and distance-based curriculum development and assessment, technology-enhanced assessment/learning, experiential education, and continuing professional education and development.

Dr. Franson is a U.S. Board-Certified Psychiatric Pharmacist and Dutch-Certified Clinical Pharmacologist. She worked with geriatric psychiatric patients for 10 years and has performed a variety of clinical studies spanning those in early-phase clinical pharmacology to post-marketing clinical efficacy studies. She is interested in cannabinoid clinical pharmacologic effects and cannabis user safety. She has guided national and international professional, legislative, media and commercial groups on the wise study and use of cannabis.

read more +

Danielle Goldfarb, MD

Assistant Professor, Departments of Neurology and of Psychiatry, University of Arizona College of Medicine, Phoenix, AZ

Dr. Danielle Goldfarb is an Assistant Professor of Neurology and Psychiatry at the University of Arizona and a dual board-certified neurologist and psychiatrist at the Banner Sun Health Research Institute and Cleo Roberts Memory Center in Sun City, AZ.  Dr. Goldfarb cares for patients and families with Alzheimer’s disease and related dementias (ADRD). She leads several Alzheimer’s clinical trials and is involved in research efforts to explore the neuropathologic substrates of early neuropsychiatric symptoms in ADRD, to improve the safety and efficiency of  the collection of cerebrospinal fluid biomarkers in older adults, and to expand access to ADRD care and research by underserved communities.

read more +

Napoleon B. Higgins, Jr., MD

Executive Director, Black Psychiatrists of America

Dr. Napoleon B. Higgins, Jr. is a child, adolescent and adult psychiatrist in Houston, Texas. He is the owner of Bay Pointe Behavioral Health Services and South East Houston Research Group.

Dr. Higgins received his MD from Meharry Medical College in Nashville, Tennessee, and he completed his residency in Adult Psychiatry and his fellowship in Child and Adolescent Psychiatry at University of Texas Medical Branch at Galveston. He is the President of the Black Psychiatrists of Greater Houston, Past President of the Caucus of Black Psychiatrists of the American Psychiatric Association and Past President of the Black Psychiatrists of America, Inc.

Dr. Higgins is co-author of How Amari Learned to Love School Again: A Story about ADHD, Mind Matters: A Resource Guide to Psychiatry for Black Communities and author of Transition 2 Practice: 21 Things Every Doctor Must Know in Contract Negotiations and the Job Search. He also specializes in nutrition and health to improve patients’ lives mentally and physically. He emphasizes that good mental and physical health are key in the practice of psychiatry and medicine.

Dr. Higgins has worked with and founded many programs that help to direct inner-city young men and women to aspire to go to college and finish their educational goals. He has worked with countless community mentoring programs and has special interest in trauma, racism, and inner-city issues and how they affect minority and disadvantaged children and communities.

read more +

Amber Hoberg, MSN, APRN, PMHNP-BC

Morning Star Family Medicine PLLC, Floresville, TX

Ms. Amber Hoberg received her Master’s degree from the University of Texas Health Science Center in San Antonio, Texas. She completed clinical internship training at Alamo Mental Health Group, Laurel Ridge Treatment Center, Genesis Psychiatric Center, and La Paz Mental Health Center in San Antonio.

Ms. Hoberg is recognized as an Advanced Practice Nurse and as a Registered Nurse by the State of Texas and is certified as an Advanced Practice Nurse by the American Nurses Credentialing Center. Amber's areas of special interest are medication management, intellectually disabled, adult and geriatric mental health care.

read more +

Mary C. Kimmel, MD

Assistant Professor; Co-Director, Perinatal Psychiatry Program; Medical Director, NC Maternal Mental Health MATTERS Program; University of North Carolina School of Medicine, Chapel Hill, NC

Dr. Mary C. Kimmel was the medical director for five years for the UNC’s Perinatal Psychiatry Inpatient Unit, the first unit of its kind in the United States to provide inpatient psychiatric care to pregnant and postpartum women, providing care to individuals with treatment resistant depression, OCD, and postpartum psychosis. The NC Maternal Mental Health MATTERS program provides education and support to frontline providers in the care of their pregnant and postpartum patients through screening, assessment and treatment of stress, anxiety, depression, and other behavioral health disorders.

Dr. Kimmel’s research is focused on the microbiota-gut-brain axis and stress reactivity across pregnancy and the postpartum period and in relation to the development of maternal depression and anxiety and the child’s development.  Specific focus is on heart rate variability as it represents the Autonomic Nervous System, immune system markers, and the microbiome as a marker of the host-environment interface.  The NIMH, HRSA, Brain & Behavior Research Foundation and the Foundation of Hope funding support Dr. Kimmel’s work.

read more +

Carolina A. Klein, MD

Assistant Medical Director, and Lead Psychiatrist for Advancement and Innovation, California Department of State Hospitals Clinical Operations Division, Sacramento, CA

Assistant Clinical Professor, University of California at Davis, Davis, CA

Dr. Carolina A. Klein is a triple-board-certified psychiatrist (General, Forensic, Addiction), who has a 15-year background in large public sector hospitals as well as private healthcare environments. She is well-versed in all elements of organizational management, regulatory guidelines, and patient care. Accomplished in hard-turnarounds of struggling organizations, focused on developing robust delivery systems producing exceptional results. Experienced in healthcare and business administration with success in program design and development. She offers clinical care to adults suffering from a broad range of mental health conditions.

Dr. Klein is currently the Assistant Medical Director at the California Department of State Hospitals, Lead Psychiatrist of Advancement and Innovational, where she oversees Forensic Services, Academic Development and Psychiatric quality of care and innovative program implementation. Concurrently, she also works as a consultant for medicolegal (forensic) matters and provides psychiatric expert witness services in civil, criminal, institutional, and regulatory arenas. She is available for expert witness testimony, attorney counsel, or institutional consultation.

Dr. Klein is actively involved in academic development and served as the Associate Program Director of the Forensic Psychiatry Fellowship Training Program at Georgetown University Hospital. She currently holds faculty appointments at Touro University and UC Davis.
Dr. Klein is also an active member of the American Academy of Psychiatry and the Law (AAPL), the American Academy of Forensic Sciences (AAFS), and the Baltimore Washington Center for Psychoanalysis (BWCP).

Dr. Klein is a Clinical Assistant Professor of Psychiatry at UC Davis.
Her special areas of interest include psychiatric diagnosis, management standards, detection of malingering, criminal responsibility evaluations, dangerousness and mitigation, psychiatric and forensic neuropsychiatric autopsies, testamentary capacity, diminished capacity, International Forensics, and death penalty matters. Other areas of special clinical and forensic interest include the forensic neuropsychiatric evaluation of medical complications of psychiatric illness and its medications, as well as psychiatric complications of medical illness.

Dr. Klein is fluent in spoken and written Spanish and can conduct evaluations for Spanish-speaking populations.

read more +

James L. Knoll, IV, MD

Professor of Psychiatry, Director of Forensic Psychiatry, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY

Clinical Director, Central New York Psychiatric Center, Marcy, NY

Dr. James L. Knoll, IV, is Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, NY, and Clinical Director of Central New York Psychiatric Center (CNYPC) in Marcy, NY. CNYPC consists of a 220 bed maximum security inpatient forensic psychiatric hospital, and 225 bed state of the art Sex Offender Treatment Program. Dr. Knoll has been SUNY Upstate’s Director of Forensic Psychiatry since 2006.

Prior to moving to New York, he was the Director of Psychiatric Treatment Services for the entire New Hampshire State Prison system and was responsible for oversight of New Hampshire’s insanity acquitee patient population. He has served as an expert witness in cases of national prominence such as the “Cleveland Strangler” serial murder case of Anthony Sowell, and the “137 shots” Cleveland Police shooting case. He has performed psychiatric fitness for duty evaluations of astronaut candidates for NASA. He is board certified in both general and forensic psychiatry.

Dr. Knoll has researched the phenomenon of murder-suicide and has interviewed surviving members of the Jonestown Tragedy mass homicide-suicide. He has presented as part of the Sandy Hook Promise initiative after the Newtown Tragedy and published an Afterword in David Kaczynski’s autobiography which details his discovery that his brother was the Unabomber (Every Last Tie: The Story of the Unabomber and His Family). For the past decade, he has performed forensic evaluations of students who have threatened to engage in violence such as school shootings. He has conducted research and published numerous articles about mass murder and was an invited consultant to the National Institute of Justice regarding mass shootings. He serves as the committee chair on threat assessment for the Onondaga County School Safety Task Force.

Dr. Knoll is Emeritus Editor-in-Chief of the Psychiatric Times (psychiatrictimes.com), one of the most widely read publications in the field of psychiatry, and a contributing editor for the Correctional Mental Health Report (civicresearchinstitute.com). He serves as director for the SUNY Upstate Forensic Psychiatry Fellowship training program and lectures nationally and internationally. He is an Affiliate Fellow of the International Criminal Investigative Analysis Fellowship (ICIAF) which serves to train and collaborate with law enforcement nationally and internationally, with regular meetings at the FBI National Academy (iciaf.org). He is teaching faculty for the annual American Academy of Psychiatry and the Law (AAPL) Forensic Psychiatry Review Course and has authored over 150 publications in journals and book chapters.

Dr. Knoll has enjoyed co-facilitating trauma and healing seminars at the Karma Triyana Dharmachakra Buddhist monastery in Woodstock, NY. He holds a first-degree black belt in Brazilian Jiu Jitsu and enjoys playing guitar.

read more +

Roger S. McIntyre, MD, FRCPC

Professor, Departments of Psychiatry and of Pharmacology; Head, Mood Disorders Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
Professor, Guangzhou Medical University, Guangzhou, China
Professor, College of Medicine, Korea University, Seoul, Republic of Korea,
Professor, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA
Professor, University of California School of Medicine, Riverside, California, USA
Chairman and Executive Director, Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada
Director and Chair, Scientific Advisory Board, Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois, USA

Dr. Roger S. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. 

Dr. McIntyre was named by Thomson Reuters in 2014 and 2015, as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.    

Dr. McIntyre is involved in multiple research endeavors which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. 

Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

Dr. McIntyre is a contributor to the “Florida Medicaid Drug Therapy Management Program for Behavioral Health: Guidelines for the treatment of adults with Major Depressive Disorder and Bipolar Disorder”. Dr. McIntyre is also the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the “CANMAT Guidelines for the Treatment of Depressive Disorders and Bipolar Disorders”. Dr. McIntyre has published hundreds of peer-reviewed articles and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

read more +

Jonathan M. Meyer, MD

Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA

Dr. Jonathan M. Meyer is a graduate of Stanford University and Harvard Medical School and finished his adult psychiatry residency at Los Angeles County-USC Medical Center. At LA County-USC he subsequently completed fellowships in Consultation/Liaison Psychiatry and Psychopharmacology Research.

In addition to teaching duties at UC San Diego, Dr. Meyer has performed extensive research on the metabolic effects of antipsychotics, and the impact of antipsychotic medications on glucose-insulin homeostasis. Dr. Meyer has published numerous articles and book chapters on various aspects of antipsychotic psychopharmacology including the pharmacokinetics of oral and depot antipsychotics, metabolic effects of atypical antipsychotics, as well as on the health care outcomes in patients with severe mental illness.

Dr. Meyer is a national speaker on the subject of side effects and metabolic issues surrounding antipsychotic therapy, is chief editor of Medical Illness and Schizophrenia, now in its 2nd edition, and is the sole author of the chapter on the “Pharmacotherapy of Psychosis and Mania” in the last two editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics.

read more +

Adelaide S. Robb, MD

Distinguished Endowed Professor and Chair, Division of Psychiatry and Behavioral Sciences, Children's National Hospital, The George Washington University School of Medicine and Health Sciences, Washington, DC

Dr. Adelaide S. Robb is a psychopharmacologist with ongoing research studies in depression and mood disorders, anxiety and attention deficit disorder. She is Chief of the Division of Psychiatry and Behavioral Sciences. 

Dr. Robb, who trained at Johns Hopkins University and the National Institutes of Health, has been on the medical staff in the Division of Psychiatry and Behavioral Medicine since 1996, rising to the rank of Professor (with tenure). She is an internationally known clinical researcher and has participated in and led multiple therapeutic trials for children with a variety of behavioral and psychiatric conditions. 

Dr. Robb is currently a tenured Professor of Psychiatry and of Pediatrics at George Washington University School of Medicine and Health Sciences and Director of Psychiatry Research at the Center for Translation Science within Children’s National. Dr. Robb’s research focus is in psychopharmacology.

read more +

Christine Y. Moutier, MD

Chief Medical Officer, American Foundation for Suicide Prevention, New York, NY
Clinical Professor, Department of Psychiatry, Columbia University, New York City, NY

Dr. Christine Y. Moutier knows the impact of suicide firsthand. After losing colleagues to suicide, she dedicated herself to fighting this leading cause of death. As a leader in the field of suicide prevention, Dr. Moutier joined AFSP as Chief Medical Officer in 2013, and it’s through her passion and commitment that we see a lasting impact via research, education and support to communities across the U.S.

Dr. Moutier has testified before the U.S. Congress and provided multiple Congressional briefings on suicide prevention. She has presented to the White House and at the National Academy of Sciences, she co-anchored CNN’s Emmy Award winning Finding Hope suicide prevention town hall, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, the BBC, CNN, NBC and other print and television outlets.

Since earning her medical degree and training in psychiatry at the University of California, San Diego, Dr. Moutier has been a practicing psychiatrist, professor of psychiatry, dean in the medical school, and medical director of the Inpatient Psychiatric Unit at the VA Medical Center in La Jolla, treating diverse patient populations from Asian refugees to veterans to corporate and academic leaders.

Dr. Moutier has authored a clinical suicide prevention handbook which released in 2021, and numerous articles and book chapters for medical and general audiences. Most recently, co-led a partnership effort with the American Academy of Pediatrics (AAP), AFSP and NIMH to establish a new National Blueprint for Youth Suicide Prevention, being released in early 2022.

read more +

William M. Sauvé, MD

Regional Medical Director—Virginia, Greenbrook TMS NeuroHealth Centers

Dr. William M. Sauvé is a Regional Medical Director for Greenbrook TMS NeuroHealth Centers, a dedicated center for the treatment of depression and OCD using Transcranial Magnetic Stimulation.

After receiving his medical degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, Dr Sauvé completed his residency in adult psychiatry in the National Capital Consortium in Washington, DC, which includes the National Naval Medical Center in Bethesda, Walter Reed Army Medical Center in Washington, DC, and Malcolm Grow Medical Center at Andrews Air Force Base in Maryland. Shortly afterward, he was deployed to the Al Anbar Province, Iraq, as the regimental psychiatrist for the 7th Marine Regiment. After 11 years of active-duty service, he left the US Navy to become Military Clinical Director at Poplar Springs Hospital. After 3 years there, he left hospital work to dedicate his full time to Transcranial Magnetic Stimulation, a practice that has now grown to over 100 dedicated TMS centers around the country. Dr Sauvé is certified by the American Board of Psychiatry and Neurology, Inc.

Dr Sauvé coauthored “The Science of Transcranial Magnetic Stimulation” with Laurence Crowther for the July issue of Psychiatric Annals. He is a member of the American Psychiatric Association and a Faculty Member at the Neuroscience Education Institute.

read more +

Thomas L. Schwartz, MD

Professor and Chair, Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY

Dr. Thomas L. Schwartz is active on many teaching, administrative and curriculum committees at SUNY, he also provides direct resident supervision, lectures in several courses, and directs and organizes continuing medical education events for the psychiatry department.

Dr. Schwartz received his medical degree from and completed his residency in adult psychiatry at the State University of New York (SUNY) Upstate Medical University in Syracuse, New York.

Dr. Schwartz’s abilities as a medical educator have been recognized with the Marc H. Hollander, MD, Psychiatry Award, Teacher of the Year, and Mentor of the Year awards from SUNY Upstate Medical University; Nancy Roeske, MD, Irma Bland, Certificates of Recognition for Excellence in Medical Student and Resident Education from the American Psychiatric Association, the SUNY Upstate President’s and the SUNY Chancellor’s Award for Teaching.   

Dr. Schwartz is the author of Practical Psychopharmacology: Basic to Advanced Principles, "Stahl’s Essential Psychopharmacology” Case Studies Volume 2, Integrating Psychotherapy and Pharmacotherapy, Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Second and Third Generation Antipsychotics.  He is the editor of Depression: Treatment Strategies and Management, 1st and 2nd Eds. and is the Deputy Editor for the journal CNS Spectrums.

read more +

Charles L. Scott, MD

Chief, Division of Psychiatry and the Law; Training Director, Forensic Psychiatry Residency Program; Professor of Clinical Psychiatry; Department of Psychiatry and Behavioral Sciences; University of California, Davis Medical Center, Sacramento, CA

Dr. Charles L. Scott is Chief, Division of Psychiatry and the Law, Forensic Psychiatry Fellowship Training Director, and Professor of Clinical Psychiatry at the University of California, Davis Medical Center in Sacramento, California. He is Board Certified in Forensic Psychiatry, General Psychiatry, Child and Adolescent Psychiatry, and Addiction Psychiatry. Dr. Scott is a Past-President of the American Academy of Psychiatry and the Law (AAPL) and is also Past-President of the Association of Directors of Forensic Psychiatry Fellowships. He has served as a member of the AAPL national task force to develop guidelines for the evaluation of criminal responsibility and competency to stand trial. Dr. Scott is one of four national AAPL Forensic Psychiatry Review Course Faculty instructors and in 2008 received the AAPL award as the most outstanding forensic psychiatry fellowship program instructor in the United States.

Dr. Scott has served as a forensic psychiatric consultant to jails, prisons, maximum security forensic inpatient units, California Department of State Hospitals, and as a consultant to the National Football League (NFL) providing training on violence risk assessment for NFL counselors. He has performed suitability evaluations for NASA’s Astronaut Selection Board. His academic subspecialty is child and adolescent forensic psychiatry. Dr. Scott has authored book chapters on juvenile violence, mental health law, and co-authored chapters on child psychiatry and the assessment of dangerousness. He has served as editor or co-editor for numerous books and is co-editor of the Third Edition of Principles and Practice of Forensic Psychiatry.

Dr. Scott's research interests include the relationship of substance use to aggression among criminal defendants, on the quality of forensic evaluations of criminal responsibility, child witness testimony, malingering, and assessment of posttraumatic stress disorder. He lectures nationally on the topics of malingering, violence risk assessment, juvenile violence, substance use and violence, the assessment of sex offenders, correctional psychiatry, DSM-5 and the law, and malpractice issues in mental health.

read more +

Manpreet K. Singh, MD, MS

Associate Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA

Dr. Manpreet K. Singh is Associate Professor of Psychiatry and Behavioral Sciences, and leads a program aimed to accelerate understanding and treatment in youth with or at high risk for developing lifelong mood disorders.

Dr. Singh earned her MD at Michigan State University and her MS at University of Michigan. She completed her combined residency training in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center. After two years of T32 postdoctoral training at Stanford’s Center for Interdisciplinary Brain Sciences Research, she joined the faculty in 2009.

Dr. Singh leads a multidisciplinary team that evaluates and treats youth with a spectrum of mood disorders as young as age 2 and well into their 20s. Her NIMH and industry funded studies examine mechanisms underlying mood disorders and apply cutting edge strategies to directly modulate the brain using transcranial magnetic stimulation and real time neurofeedback. She is also investigating the efficacy and safety of pharmacotherapies and psychotherapies, such as family focused psychotherapy and mindfulness meditation, to reduce mood symptoms and family stress. All of these areas of research aim to elucidate core mechanisms underlying mood disorders and how treatment early in life can pave the path to more adaptive outcomes.

In her spare time, Dr. Singh enjoys traveling and hiking with her husband and three children, and avidly teaches Indian classical music.

read more +

Jeffrey R. Strawn, MD

Professor, Departments of Pediatrics and of Psychiatry and Behavioral Neuroscience and of Clinical Pharmacology, University of Cincinnati College of Medicine, Cincinnati, OH

Clinical Psychiatrist, University of Cincinnati Medical Center, UC Health; and Cincinnati Children's Hospital Medical Center, Division of Child & Adolescent Psychiatry; Cincinnati, OH

Dr. Jeffrey R. Strawn's early work examined the neurophysiology, neurochemistry and neuroanatomy of anxiety disorders in children and adolescents. His examination of cortical thickness in adolescents with anxiety, revealed abnormalities in cortical thickness in an ensemble of regions responsible for fear learning, fear extinction, reflective functioning (e.g., mentalization), and regulation of the amygdala. Additionally, gray matter volumes in youth with anxiety disorders are greater in the dorsal anterior cingulate and decreased in the ventrolateral prefrontal cortex), cuneus/precuneus, as well as decreased amygdala gray matter volumes in the amygdala which is consistent with his functional MRI data suggesting increased activation in youth with anxiety disorders, relative to healthy comparison subjects, during a continuous processing task with emotional and neutral distractors. Additionally, from a neurochemistry standpoint, he has demonstrated that glutamatergic tone in the anterior cingulate cortex is directly linked with anxiety symptom severity in youth with anxiety. These studies suggest that anxiety disorders are associated with structural, functional and neurochemical abnormalities with prefrontal-amygdala circuitry. By providing evidence of these structural, functional and neurochemical abnormalities, this body of work has propelled additional studies of these structures in youth who are at risk for developing anxiety disorders and in studies which have allowed the integration of psychopharmacologic treatment studies with neuroimaging evaluations of anxious youth.

In parallel with Dr. Strawn's work on the neurophysiology of mood and anxiety disorders in children and adolescents, he has worked to increase the evidence base for treatment interventions in youth. Using meta-analysis, he demonstrated that antidepressants are well-tolerated in pediatric patients with anxiety disorders, but also examined specific class-specific side effects (e.g., activation). Also, he has examined the unique tolerability of antidepressants in special populations of adolescents with depressive and anxiety disorders (e.g., those who are at high risk for the development of bipolar disorder) and has observed that antidepressants are poorly tolerated in this population with likelihood of antidepressant adverse events leading to discontinuation being directly related to age. Additionally, he has extensive expertise in the conduct of double blind, placebo-controlled trials in youth with anxiety disorders. As an example, with his collaborators, they demonstrated the efficacy of duloxetine in a double-blind placebo controlled trial of duloxetine which culminated in a FDA indication for duloxetine in children and adolescents with GAD (age 7-17).

read more +

Katherine Warburton, DO

Associate Professor, Clinical Forensic Psychiatry, Division of Psychiatry and the Law, Department of Psychiatry and Behavioral Sciences, University of California, Davis, School of Medicine, Sacramento, CA

Medical Director and Deputy Director of Clinical Operations, California Department of State Hospitals

Dr. Katherine Warburton is Medical Director/Deputy Director of Clinical Operations for the California Department of State Hospitals. Prior to that, she was the Chief of Forensic Psychiatry at Napa State Hospital. She is on the volunteer clinical faculty of the UC Davis Division of Psychiatry and the Law.

read more +

Timothy E. Wilens, MD

Chief, Division of Child and Adolescent Psychiatry; Director, Substance Abuse Services in Pediatric Psychopharmacology; Co-Director, Center for Addiction Medicine; Massachusetts General Hospital for Children, Boston, MA

Professor, Department of Psychiatry, Harvard Medical School, Boston, MA

Dr. Timothy E. Wilens is chief of the Division of Child and Adolescent Psychiatry at Massachusetts General Hospital (MGH), (co) director of the Center for Addiction Medicine at MGH, and the MGH Trustees Chair in Addiction Medicine. He is a professor of Psychiatry at Harvard Medical School.

Dr. Wilens earned his BS in literature, science, and arts at the University of Michigan Honors College and his MD at the University of Michigan Medical School in Ann Arbor. His residency in child, adolescent and adult psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School. He is triple board certified in child/adolescent, adult, and addiction psychiatry.

Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models, and the pharmacotherapy of ADHD across the lifespan. He has published more than 300 peer-reviewed articles, concerning these and related topics, in prestigious journals such as JAMA, American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. Dr. Wilens has also coedited/published more than 80 book chapters, 4 books, and 300 abstracts and presentations for national and international scientific meetings.

Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry (AACAP), serves as the chair of new research and psychopharmacology committees for AACAP, is on the editorial boards or is a scientific reviewer for more than 35 journals, and is active in a number of other local and national professional societies.

Dr. Wilens is named consistently among “The Best of Boston” in Child/Adult Psychiatry and “The Best Doctors in America.”

read more +

Jade Wu, PhD, DBSM

Associate in Research, Duke University School of Medicine, Durham, NC

Dr. Jade Wu is a Board-certified behavioral sleep medicine specialist and sleep health researcher at Duke University School of Medicine. She earned her Bachelor’s degree at Cornell University, completed her PhD at Boston University, and finished her medical psychology residency and clinical fellowship at Duke. Her current research focuses on treating sleep disorders in those with chronic illness and health risk factors such as hypertension.

read more +

*Faculty subject to change